期刊文献+

耐甲氧西林金黄色葡萄球菌血流感染的临床特征及易感因素分析 被引量:12

Clinical characteristics and risk factors of bloodstream infection caused by methicillin-resistant Staphylococcus aureus
下载PDF
导出
摘要 目的:了解耐甲氧西林金黄色葡萄球菌(MRSA)血流感染患者的临床特征,探究其易感因素。方法:回顾分析空军总医院MRSA及甲氧西林敏感的金黄色葡萄球菌(MSSA)血流感染患者,比较两组患者临床资料,归纳总结MRSA血流感染的临床特征及其易感因素。结果:MRSA血流感染原发灶多为导管相关性感染,而MSSA感染多来源于皮肤软组织。细菌分离阳性前MRSA组患者住院时间长于MSSA组(P<0.05),总住院时间和细菌分离阳性后住院时间,差异无统计学意义(P>0.05)。MRSA组病死率、TTP(血培养阳性报警时间)、合并休克及多脏器功能衰竭的发生率均高于MSSA组(P<0.05)。多因素分析显示年龄>65岁、TTP是MRSA感染的独立危险因素,皮肤病是MSSA感染的独立危险因素。ROC曲线表明TTP>19.41 h可作为区分MRSA及MSSA的切点,曲线下面积为0.811。结论:MRSA感染并发症重,住院时间的延长导致MRSA感染风险增加。TTP>19.41 h可作为MRSA血流感染的早期预警指标,预测MRSA血流感染的准确度为中等。 Objective To explore the clinical characteristics and risk factors of bloodstream infections caused by methicillin-resistant Staphylococcus aureus. Methods The clinical features,laboratory manifestations,diagnosis and treatment of patients with MRSA and MSSA bloodstream infection in the Air Force Hospital of PLA were analyzed retrospectively. Results The primary infection site of MRSA group was mainly catheter related infection, while it was mainly skin and soft tissue in MSSA group. Before infection,the hospital stay of MRSA group was longer than MSSA group(P〈0.05).There was no significant difference between the two groups in the total length of hospital stay and the days after bacterial separation(P〉0.05). Compared with the MSSA group,the mortality rate, the incidence of combined shock and multiple organ failure were higher than that of MSSA group(P〈0.05). The time to blood culture positivity(TTP)of MRSA was longer than MSSA group(P〈0.01).Multivariate analysis showed that patients with age over 65 years old and TTP were independent risk factors for MRSA infection(P〈0.05). While skin disorder was the protective factor of MRSA, which was the independent risk factor of MSSA bloodstream infection. ROC curve showed that TTP 19.41 h was the optimal cutoff to distinguish MRSA and MSSA, with area under the ROC curve(AUC)of 0.811. Conclusion The complications of MRSA infection were severe. Prolonged hospital stay contributes to increasing risk of MRSA infection. TTP which is more than 19.41 h can be used as an early warning indicator of MRSA and the accuracy is moderate.
出处 《实用医学杂志》 CAS 北大核心 2016年第20期3412-3415,共4页 The Journal of Practical Medicine
关键词 耐甲氧西林金黄色葡萄球菌 甲氧西林敏感金黄色葡萄球菌 血流感染 易感因素 临床分析 Methicillin-resistant Staphylococcus aureus Methicillin-susceptible Staphylococcus aureus Bloodstream infection Susceptible factors Clinical analysis
  • 相关文献

参考文献14

  • 1李光辉,朱德妹,汪复,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET血培养临床分离菌的分布及耐药性[J].中国感染与化疗杂志,2014,14(6):474-481. 被引量:148
  • 2HORAN TC, ANDRUS M, DUDECK MA. CDC/NHSNsurveillance definition of health care-associated infection andcriteria for specific types of infections in the acute care setting[J].Am J Infect Control,2008,36(5): 309-332.
  • 3M100-S23 ,Performance standards for antimicrobial susceptibilitytesting; twenty-third informational supplement [S].Wayne,PA:NCCLS, CLSI document, 2013.
  • 4ASLAM N, MEHDIN, IZHAR M. Root cause analysis ofmethicillin resistant Staphylococcus aureus bacteraemia [J].JPak Med Assoc, 2015,65(10):1089-1093.
  • 5YASMIN M,El HAGE H, OBEID R, et al. Epidemiology ofbloodstream infections caused by methicillin-resistantStaphylococcus aureus at a tertiary care hospital in New York[J].Am J Infect Control, 2016,44(1) :41-46.
  • 6ATMACA 0,ZARAKOLU P, KARAHAN C, et al. Risk factorsand antibiotic use in methicillin-resistant Staphylococcus aureusbacteremia in hospitalized patients at Hacettepe University Adultand Oncology Hospitals (2004 -2011) and antimicrobialsusceptibilities of the isolates: a nested case-control study [J].Mikrobiyol Bui, 2014,48(4):523-537.
  • 7CASTILLO JS, LEAL AL, CORTES JA, et al. Mortality amongcritically ill patients with methicillin-resistant Staphylococcusaureus bacteremia: a multicenter cohort study in Colombia [J].Rev Panam Salud Publica, 2012,32(5) : 343-350.
  • 8周龙,乔甫,黄文治,宗志勇.血流感染耐甲氧西林金黄色葡萄球菌对患者预后的影响[J].中国感染控制杂志,2015,14(1):27-30. 被引量:10
  • 9DE KRAKER ME, WOLKEWITE M, DAVEY PG, et al.Clinical impact of antimicrobial resistance in Europeanhospitals: excess mortality and length of hospital stay related tomethicillin-resistant Staphylococcus aureus bloodstreaminfections [J].Antimicrob Agents Chemother, 2011,55 (4):1598-1605.
  • 10SIMORAE,PELUDE L, GOLDING G, et al. Determinants ofOutcome in Hospitalized Patients With Methicillin-ResistantStaphylococcus aureus Bloodstream Infection : Results FromNational Surveillance in Canada, 2008-2012 [J].Infect ControlHosp Epidemiol,2016,37(4) :390-397.

二级参考文献27

  • 1Isturiz R. Global resistance trends and the potential impact on empirical therapy[J]. Int J Antimicrob Agent, 2008,32(S4):S201-S206.
  • 2Lee S Y, Kotapati S, Kuti J L, et al. Impact of extendedspectrum betalactamase producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study[J]. Infect Control Hosp Epidemiol, 2006,27(11):1226- 1232.
  • 3Cosgrove S E,Qi Y L,Kaye K S,et al. The impact of methicillinresistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges[J]. Infect Control Hosp Epidemiol,2005,26(2):166-174.
  • 4Cosgrove S E, Sakoulas G, Perencevich E N, et al. Comparison of mortality associated with methicillinresistant and methicillinsusceptible Staphylococcus aureus bacteremia :a metaanalysis[J]Clin Infect Dis,2003,36(1):53-59.
  • 5Whitby M, McLaws M L, Berry G. Risk of death from methicillinresistant Staphylococcus aureus bacteremia: a metaanalysis[J]. Med J Aust, 2001;175(5):264-267.
  • 6European Centre for Disease Prevention and Control/European Medicines Agency (ECDC/EMEA). Joint technical report the bacterial challenge: time to react[C]. Stockholm:ECDC/ EMEA,2009.
  • 7BenDavid D, Novikov I, Mermel L A. Are there differences in hospital cost between patients with nosocomial methicillinresistant Staphylococcus aureus bloodstream infection and those with methicillinsusceptible S.aureus bloodstream infection?[J]. Infect Control Hosp Epidemiol,2009,30(5):453-460.
  • 8Laverty G, Gorman SP,Gilmore BF. Biomolecular mechanismsof staphylococcal biofilm formation [J]. Future Microbiol, 2013,8(4);509-524.
  • 9Arciola CR, Campoccia D, Speziale P, et al. Biofilm formationin Staphylococcus implant infections. A review of molecularmechanisms and implications for biofilm-resistant materials [J],Biomaterials,2012,33(26):5967-5982.
  • 10O'Neill E, Pozzi C, Houston P, et al. Association betweenmethicillin susceptibility and biofilm regulation inStaphylococcus aureus isolates from device-related infections[J].J Clin Microbiol, 2007,45(5): 1379-1388.

共引文献166

同被引文献151

引证文献12

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部